UBS Knock-Out ABT/ DE000UH5VEK2 /
2024-04-30 9:42:36 PM | Chg.+0.08 | Bid10:00:14 PM | Ask10:00:14 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.71EUR | +2.20% | - Bid Size: - |
- Ask Size: - |
Abbott Laboratories | 144.9576 USD | 2078-12-31 | Put |
GlobeNewswire
03-25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
03-15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
2023-11-14
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
2023-10-19
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
2023-10-10
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
2023-10-02
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors
GlobeNewswire
2023-09-06
Endexx Corporation Appoints Ahmed Itani to Director of Marketing of HYLA in The Middle East Region